DE69427970D1 - Medikament gegen atopische krankheiten - Google Patents

Medikament gegen atopische krankheiten

Info

Publication number
DE69427970D1
DE69427970D1 DE69427970T DE69427970T DE69427970D1 DE 69427970 D1 DE69427970 D1 DE 69427970D1 DE 69427970 T DE69427970 T DE 69427970T DE 69427970 T DE69427970 T DE 69427970T DE 69427970 D1 DE69427970 D1 DE 69427970D1
Authority
DE
Germany
Prior art keywords
atopic diseases
medicine against
against atopic
medicine
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69427970T
Other languages
English (en)
Other versions
DE69427970T2 (de
Inventor
Shiro Iino
Yoshiharu Kawashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69427970D1 publication Critical patent/DE69427970D1/de
Application granted granted Critical
Publication of DE69427970T2 publication Critical patent/DE69427970T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69427970T 1994-01-28 1994-01-28 Medikament gegen atopische krankheiten Expired - Fee Related DE69427970T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1994/000124 WO1995020395A1 (fr) 1994-01-28 1994-01-28 Medicament contre des maladies atopiques

Publications (2)

Publication Number Publication Date
DE69427970D1 true DE69427970D1 (de) 2001-09-20
DE69427970T2 DE69427970T2 (de) 2001-11-29

Family

ID=14098153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427970T Expired - Fee Related DE69427970T2 (de) 1994-01-28 1994-01-28 Medikament gegen atopische krankheiten

Country Status (6)

Country Link
US (1) US5709853A (de)
EP (1) EP0694307B1 (de)
JP (1) JP3269125B2 (de)
KR (1) KR100278351B1 (de)
DE (1) DE69427970T2 (de)
WO (1) WO1995020395A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675732B1 (de) * 1993-07-27 2006-06-28 Mario Bigazzi Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
US6121247A (en) * 1996-03-29 2000-09-19 The Johns Hopkins University Therapy for allergic diseases
JP3845915B2 (ja) * 1996-10-31 2006-11-15 東レ株式会社 ネコのアトピー性皮膚炎治療剤および治療方法
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US8914114B2 (en) * 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
CA2476896A1 (en) * 2002-02-26 2003-09-04 North Shore-Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US8729129B2 (en) * 2004-03-25 2014-05-20 The Feinstein Institute For Medical Research Neural tourniquet
AU2005323463B2 (en) 2004-12-27 2009-11-19 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US8571662B2 (en) 2007-01-29 2013-10-29 Simon Fraser University Transvascular nerve stimulation apparatus and methods
CA2680477A1 (en) * 2007-03-13 2008-09-18 The Feinstein Institute For Medical Research Treatment of inflammation by non-invasive stimulation
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
WO2009146030A1 (en) * 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
EP2355893B1 (de) * 2008-11-18 2013-12-25 Setpoint Medical Corporation Vorrichtungen zur optimierung der elektrodenplatzierung für antientzündungsstimulationen
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (de) * 2009-06-09 2018-09-12 Setpoint Medical Corporation Nervenmanschette mit tasche für einen bleifreien stimulator
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
CN105126248B (zh) * 2009-12-23 2018-06-12 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
DE102011052816A1 (de) * 2011-08-18 2013-02-21 Tigo Gmbh Verwendung von Interferon-beta zur Behandlung von Alopecia areata
EP3556427B1 (de) 2012-03-05 2022-06-08 Lungpacer Medical Inc. Transvaskuläre nervenstimulationsvorrichtung
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
CA3161433A1 (en) 2012-06-21 2023-01-27 Lungpacer Medical Inc. Transvascular diaphragm pacing systems and methods of use
EP3760276B1 (de) 2013-11-22 2023-08-30 Lungpacer Medical Inc. Vorrichtung für unterstützte atmung durch transvaskuläre nervenstimulation
CA2935454A1 (en) 2014-01-21 2015-07-30 Simon Fraser University Systems and related methods for optimization of multi-electrode nerve pacing
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
EP3405255A4 (de) 2016-01-20 2019-10-16 Setpoint Medical Corporation Implantierbare mikrostimulatoren und induktive ladesysteme
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
EP4115942B1 (de) 2017-06-30 2024-04-24 Lungpacer Medical Inc. System zur vorbeugung, abschwächung und/oder behandlung von kognitiven läsionen
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
EP3668402A4 (de) 2017-08-14 2021-05-19 Setpoint Medical Corporation Vagusnervstimulationsvorscreening-test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2020097331A1 (en) 2018-11-08 2020-05-14 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US11357979B2 (en) 2019-05-16 2022-06-14 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
EP3983057A4 (de) 2019-06-12 2023-07-12 Lungpacer Medical Inc. Schaltung für medizinische stimulationssysteme
WO2021236977A1 (en) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
CA2069870E (en) * 1989-12-01 2005-01-11 Donald Y. M. Leung Treatment of atopic disorders with gamma-interferon
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬

Also Published As

Publication number Publication date
KR960700742A (ko) 1996-02-24
EP0694307A1 (de) 1996-01-31
EP0694307A4 (de) 1996-05-08
US5709853A (en) 1998-01-20
JP3269125B2 (ja) 2002-03-25
WO1995020395A1 (fr) 1995-08-03
DE69427970T2 (de) 2001-11-29
EP0694307B1 (de) 2001-08-16
JPH0648957A (ja) 1994-02-22
KR100278351B1 (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
DE69427970D1 (de) Medikament gegen atopische krankheiten
FI971279A (fi) Lääkkeitä
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
DE69606550D1 (de) Medizinischen verbindungsanordnung
DE69517317T2 (de) Medizinischer schlauch
DE69630543D1 (de) Medizinische elektrodenleitung
DE69510024T2 (de) Spritze
DE69630305D1 (de) Elektrodenkatheter
TR199600481A2 (tr) Tedavi edici amidler.
EE9700013A (et) Terapeutilised ühendid
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
BR9600809A (pt) Medicamento
BR9508339A (pt) Medicamento
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
DE59610423D1 (de) Partikulare arzneiform
DE69636790D1 (de) Interferon-beta gegen knochenerkrankungen
DK48194A (da) Medicinsk elektrode
NO962385D0 (no) Terapeutiske amider
KR960030473U (ko) 병원용 베드헤드 유니트
KR960030492U (ko) 의료용 멸균기
KR960028346U (ko) 쑥뜸기
UA915S (uk) Канюля медична
SE9401674L (sv) Läkemedel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee